STOCK TITAN

Agenus: TCG Crossover reports 9.99% passive stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Agenus Inc. (AGEN) is the subject of a Schedule 13G in which TCG Crossover Fund III, L.P., its general partner TCG Crossover GP III, LLC, and Chen Yu each report the same beneficial-ownership position: 4,954,779 shares, or 9.99%. The securities are held of record by TCG Crossover III; shared voting and dispositive power is reported.

The position comprises 603,892 common shares, 3,387,533 shares underlying Pre-Funded Warrants, and 963,354 shares underlying Series B Warrants, all exercisable within 60 days. The calculation uses 45,246,510 shares outstanding as of November 3, 2026. It excludes 3,109,452 shares underlying Series A Warrants that are not exercisable within 60 days and 4,006,824 shares underlying Series B Warrants subject to the 9.99% Beneficial Ownership Limitation. The reporting persons disclaim status as a group.

Beneficial ownership 4,954,779 shares Same position reported by each reporting person
Percent of class 9.99% Reported beneficial ownership percentage for each reporting person
Common shares 603,892 shares Component of the reported beneficial-ownership position
Pre-Funded Warrants 3,387,533 underlying shares Exercisable within 60 days
Series B Warrants 963,354 underlying shares Exercisable within 60 days
Shares outstanding 45,246,510 shares As of November 3, 2026
Series A Warrants excluded 3,109,452 underlying shares Not exercisable within 60 days
Series B Warrants excluded 4,006,824 underlying shares Excluded under the Beneficial Ownership Limitation
Pre-Funded Warrants financial
"shares of Common Stock underlying Pre-Funded Warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Series B Warrants financial
"shares of Common Stock underlying Series B Warrants"
Series B warrants are contracts issued alongside a company's Series B financing that give the holder the right to buy a set number of shares at a fixed price within a specified time. For investors, they matter because they can provide leveraged upside if the company grows, or they can dilute existing shareholders when exercised—like a coupon promising a future share at a known price that can add value or change ownership stakes.
Series A Warrants financial
"shares of Common Stock subject to Series A Warrants"
Series A warrants are financial tools that give the holder the right to buy shares of a company at a specific price within a certain period. They are often issued alongside investments to provide additional potential profit if the company's value increases. For investors, they can offer a chance to benefit from future growth without committing immediate capital to buying shares.
Beneficial Ownership Limitation regulatory
"because the Series B Warrants may not be exercised"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Agenus (AGEN) shares do the reporting persons report owning?

Each reports the same beneficial-ownership position of 4,954,779 shares, or 9.99%. The reported amount includes common shares and shares underlying Pre-Funded and Series B Warrants exercisable within 60 days.

What voting and dispositive power is reported for the Agenus (AGEN) shares?

The reporting persons report shared voting power and shared dispositive power over 4,954,779 shares, with zero sole voting power and zero sole dispositive power. TCG Crossover III holds the securities of record; its general partner and Chen Yu may be deemed to share power over them.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





00847G804

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (a) 603,892 shares of Common Stock, (b) 3,387,533 shares of Common Stock underlying Pre-Funded Warrants (the Pre-Funded Warrants) which are exercisable within 60 days of this Statement and (c) 963,354 shares of Common Stock underlying Series B Warrants (the Series B Warrants) which are exercisable within 60 days of this Statement. These securities are held of record by TCG Crossover III (as defined in Item 2(a) below). This total excludes (a) 3,109,452 shares of Common Stock subject to Series A Warrants (the Series A Warrants) which are not exercisable within 60 days of this Statement and (b) 4,006,824 shares of Common Stock underlying Series B Warrants which are not exercisable within 60 days of this Statement because the Series B Warrants may not be exercised for Common Stock to the extent that doing so would result in the holder of the Series B Warrants (together with the holder's affiliates and any other persons acting as a group together with the holder or any of the holder's affiliates) beneficially owning more than 9.99 percent of the shares of Common Stock then outstanding immediately after giving effect to such exercise (the Beneficial Ownership Limitation). TCG Crossover GP III (as defined in Item 2(a) below) is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 49,597,397 shares, as follows: (a) 45,246,510 shares of Common Stock outstanding as of November 3, 2026, as reported by the Issuer (as defined in Item 1(a) below) in its quarterly report on Form 10-Q filed with the United States Securities and Exchange Commission (the Commission) on November 5, 2026 (the Form 10-Q), plus (b) an aggregate of 4,350,887 shares of Common Stock underlying Pre-Funded Warrants and Series B Warrants which are exercisable within 60 days of this Statement.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (a) 603,892 shares of Common Stock, (b) 3,387,533 shares of Common Stock underlying Pre-Funded Warrants which are exercisable within 60 days of this Statement and (c) 963,354 shares of Common Stock underlying Series B Warrants which are exercisable within 60 days of this Statement. These securities are held of record by TCG Crossover III. This total excludes (a) 3,109,452 shares of Common Stock subject to Series A Warrants which are not exercisable within 60 days of this Statement and (b) 4,006,824 shares of Common Stock underlying Series B Warrants which are not exercisable within 60 days of this Statement due to the Beneficial Ownership Limitation. TCG Crossover GP III is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 49,597,397 shares, as follows: (a) 45,246,510 shares of Common Stock outstanding as of November 3, 2026, as reported by the Issuer in the Form 10-Q, plus (b) an aggregate of 4,350,887 shares of Common Stock underlying Pre-Funded Warrants and Series B Warrants which are exercisable within 60 days of this Statement.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (a) 603,892 shares of Common Stock, (b) 3,387,533 shares of Common Stock underlying Pre-Funded Warrants which are exercisable within 60 days of this Statement and (c) 963,354 shares of Common Stock underlying Series B Warrants which are exercisable within 60 days of this Statement. These securities are held of record by TCG Crossover III. This total excludes (a) 3,109,452 shares of Common Stock subject to Series A Warrants which are not exercisable within 60 days of this Statement and (b) 4,006,824 shares of Common Stock underlying Series B Warrants which are not exercisable within 60 days of this Statement due to the Beneficial Ownership Limitation. TCG Crossover GP III is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 49,597,397 shares, as follows: (a) 45,246,510 shares of Common Stock outstanding as of November 3, 2026, as reported by the Issuer in the Form 10-Q, plus (b) an aggregate of 4,350,887 shares of Common Stock underlying Pre-Funded Warrants and Series B Warrants which are exercisable within 60 days of this Statement.


SCHEDULE 13G



TCG Crossover GP III, LLC
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/16/2026
TCG Crossover Fund III, L.P.
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/16/2026
Chen Yu
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, as Attorney-in-Fact for Chen Yu
Date:11/16/2026
Exhibit Information

Exhibit 1 - Joint Filing Agreement

Keep reading